FBDD – Fragment Based Drug Discovery – by Sprint Bioscience

A fast route for development of new drugs.

Sprint Bioscience is a Drug Discovery company with an oncology portfolio. Our platform for fast efficient fragment based drug discovery enables our pipeline within cancer metabolism. We use this platform to offer CRO services as well as driving our portfolio of internal drug discovery projects.

Drug Development with Quality in Every Step from Day One

Post to Twitter Post to Facebook Post to LinkedIn

Comments are closed.